25 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Jaguar Health, Inc. JAGX stock rose 25.2% to $1.44 during Wednesday's pre-market session. The market cap stands at $9.3 million.
• Aptinyx, Inc. APTX shares increased by 13.8% to $3.54. The market cap stands at $112.0 million. According to the most recent rating by JP Morgan, on August 13, the current rating is at Underweight.
• Cerecor, Inc. CERC stock rose 10.7% to $4.24. The market value of their outstanding shares is at $232.7 million.
• Altimmune, Inc. ALT shares rose 9.4% to $2.33. The market cap seems to be at $106.8 million. The most recent rating by Roth Capital, on July 19, is at Buy, with a price target of $8.30.
• ARCA biopharma, Inc. ABIO stock moved upwards by 4.8% to $5.19. The market cap stands at $864.4 million.
• Genfit, Inc. GNFT stock surged 4.8% to $17.07. The market cap seems to be at $638.7 million.
• Invitae, Inc. NVTA stock rose 3.6% to $26.70.
• Viveve Medical, Inc. VIVE stock surged 3.6% to $0.12. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
• Sesen Bio, Inc. SESN shares moved upwards by 3.4% to $1.21. The most recent rating by H.C. Wainwright, on June 11, is at Buy, with a price target of $3.00.
• InMode, Inc. INMD shares surged 3.2% to $22.55.
• Mallinckrodt, Inc. MNK shares surged 3.2% to $4.67. The most recent rating by Barclays, on June 11, is at Equal-Weight, with a price target of $11.00.
• Lexicon Pharmaceuticals, Inc. LXRX stock moved upwards by 3.0% to $1.36. The market value of their outstanding shares is at $1.1 billion. The most recent rating by Citigroup, on July 30, is at Buy, with a price target of $3.00.
• Endo International, Inc. ENDP stock increased by 3.0% to $3.11. The market cap stands at $644.6 million. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $3.00.
• Teva Pharmaceutical Indus, Inc. TEVA shares moved upwards by 2.8% to $7.21. The market cap seems to be at $7.3 billion. The most recent rating by BMO Capital, on August 09, is at Market Perform, with a price target of $9.00.
• TherapeuticsMD, Inc. TXMD shares moved upwards by 2.2% to $2.80. The market cap seems to be at $1.3 billion.
• Tilray, Inc. TLRY stock increased by 2.2% to $29.94. The market cap stands at $6.3 billion. According to the most recent rating by Ladenburg Thalmann, on July 17, the current rating is at Neutral.
• Nuvectra, Inc. NVTR stock surged 2.1% to $1.48. The market cap stands at $30.7 million.

Losers

• TrovaGene, Inc. TROV shares plummeted 22.0% to $2.23 during Wednesday's pre-market session.
• Synlogic, Inc. SYBX shares fell 9.5% to $3.16. According to the most recent rating by Oppenheimer, on August 21, the current rating is at Perform.
• Outlook Therapeutics, Inc. OTLK stock plummeted 4.7% to $1.81.
• Cancer Genetics, Inc. CGIX stock declined 4.2% to $0.12. The market cap stands at $78.1 million.
• Genetic Technologies, Inc. GENE shares plummeted 3.9% to $2.19. The market cap seems to be at $12.0 million.
• VBI Vaccines, Inc. VBIV shares plummeted 3.5% to $0.61. The market cap stands at $199.7 million.
• Soliton, Inc. SOLY shares plummeted 3.2% to $12.20.
• Alcon, Inc. ALC stock fell 2.8% to $60.73. The market cap seems to be at $28.1 billion. The most recent rating by Bank of America, on August 21, is at Neutral, with a price target of $65.00.